SARTINI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.960
EU - Europa 1.788
AS - Asia 1.458
SA - Sud America 189
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 87
OC - Oceania 6
Totale 7.650
Nazione #
US - Stati Uniti d'America 3.851
IT - Italia 708
SG - Singapore 506
CN - Cina 412
DE - Germania 243
SE - Svezia 241
HK - Hong Kong 172
VN - Vietnam 157
BR - Brasile 155
AT - Austria 122
BG - Bulgaria 97
FR - Francia 85
GB - Regno Unito 82
FI - Finlandia 73
CA - Canada 70
RU - Federazione Russa 45
TR - Turchia 45
IN - India 43
CI - Costa d'Avorio 35
JP - Giappone 29
MX - Messico 20
NL - Olanda 20
BD - Bangladesh 17
UA - Ucraina 17
NG - Nigeria 14
BE - Belgio 13
IQ - Iraq 12
ZA - Sudafrica 11
AR - Argentina 10
PL - Polonia 10
ES - Italia 9
CO - Colombia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
DK - Danimarca 6
EC - Ecuador 6
ID - Indonesia 6
MA - Marocco 6
PK - Pakistan 6
SN - Senegal 6
KR - Corea 5
VE - Venezuela 5
AU - Australia 4
CH - Svizzera 4
CR - Costa Rica 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
SV - El Salvador 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
TN - Tunisia 3
AL - Albania 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
CG - Congo 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
TG - Togo 1
YE - Yemen 1
Totale 7.489
Città #
Ashburn 383
Woodbridge 307
Singapore 273
Fairfield 271
Ann Arbor 265
Serra 253
Chandler 185
Dallas 183
Hong Kong 172
Houston 172
San Jose 167
Santa Clara 162
Seattle 131
Beijing 116
Wilmington 99
Sofia 97
Cambridge 93
Vienna 92
Shanghai 90
Council Bluffs 87
New York 84
Los Angeles 59
Princeton 48
Boardman 47
Milan 45
Dong Ket 44
Ottawa 42
Helsinki 39
Lawrence 36
Abidjan 35
Frankfurt am Main 35
Rho 35
Medford 34
Lauterbourg 33
Pisa 33
Ho Chi Minh City 27
Florence 24
Tokyo 24
Nanjing 23
Izmir 22
London 22
Des Moines 20
Hanoi 20
Redondo Beach 19
São Paulo 19
Istanbul 18
Munich 18
Rome 17
Bremen 16
Lucca 15
Nürnberg 15
Buffalo 14
Lagos 14
Phoenix 14
Brussels 13
Marseille 13
Dearborn 12
Jacksonville 12
San Diego 12
Düsseldorf 11
Mumbai 11
Atlanta 9
Fuzhou 9
Ogden 9
Brooklyn 8
Columbus 8
Guangzhou 8
Tashkent 8
Toronto 8
Vancouver 8
Livorno 7
Orem 7
The Dalles 7
Warsaw 7
Amsterdam 6
Chennai 6
Dakar 6
Denver 6
Johannesburg 6
Kent 6
Nuremberg 6
Pistoia 6
Pune 6
Belo Horizonte 5
Bexley 5
Bologna 5
Capannori 5
Changsha 5
Falls Church 5
Jakarta 5
Kunming 5
Manchester 5
Mexico City 5
Nanchang 5
Poplar 5
Redwood City 5
Salvador 5
Springfield 5
Tagliacozzo 5
Turku 5
Totale 4.934
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 424
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 387
From pollen grains to functionalized microcapsules: a facile chemical route using ionic liquids 298
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 282
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 266
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 260
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 256
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 240
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 236
Functional Studies in the Year of Pulses: the case of Zolfino landraces (Phaesolus vulgaris L.) 234
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 228
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 219
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 216
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 211
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 208
pH-responsive carboxymethylcellulose nanoparticles for 68Ga-WBC labeling in PET imaging 208
Combined Use of Scanning Electron Microscopy-Energy-Dispersive X-ray Spectroscopy and Fourier Transform Infrared Imaging Coupled with Principal Component Analysis in the Study of Ancient Egyptian Papyri 197
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation 193
Chiral ionic liquids supported on natural sporopollenin microcapsules 187
FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells 185
Effects of the new aldose reductase inhibitor benzofuroxane derivative bf-5m on high glucose induced prolongation of cardiac qt interval and increase of coronary perfusion pressure 182
Imidazo[1,2- a]pyridine derivatives as aldehyde dehydrogenase inhibitors: Novel chemotypes to target glioblastoma stem cells 176
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 174
Derivati a nucleo benzo[d]isotiazol-3(2H)-one-1,1-diossido e loro impiego nel trattamento di tumori 172
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 161
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 159
Derivati a nucleo pirazolo[3,4-d]pirimidinico quali inibitori di proteine tirosina chinasi 152
A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation 152
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 149
Synthesis and Biological Evaluation of 2'-Oxo-2,3-dihydro-3'H-spiro[chromene-4,5'-[1,3]oxazolidin]3'il]acetic Acid Derivatives as Aldose reductase Inhibitors 143
Cyclodextrin-​based nanosponges for the targeted delivery of the anti-​restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention 140
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 139
Copper-Catalyzed Recyclable Synthesis of (Z )-3-Alkylideneisoindolinones by Cycloisomerization of 2-Alkynylbenzamides in Ionic Liquids 139
Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements 132
Agente terapeutico per il trattamento dei vasi sanguigni 131
Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug 119
null 109
null 104
null 82
Totale 7.650
Categoria #
all - tutte 20.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022499 0 0 21 33 85 60 29 45 36 9 30 151
2022/2023779 99 136 74 69 97 87 16 42 118 5 32 4
2023/2024374 32 33 57 15 36 81 24 5 7 18 27 39
2024/20251.243 11 45 3 85 147 159 89 63 133 159 114 235
2025/20261.610 133 149 188 164 192 117 237 89 79 173 56 33
2026/2027406 44 264 98 0 0 0 0 0 0 0 0 0
Totale 7.650